A study investigated the contribution of promoter DNA methylation of CALM2 (four CpG dinucleotides), CAMK1D (nine CpG dinucleotides), and CRY2 (five CpG dinucleotides) to T2DM risk. This evidence concerns the gene CALM2 and type 2 diabetes mellitus.